Richard Caselli
RICHARD J. CASELLI, M.D., Mayo Clinic Arizona
MEDICAL EDITOR

Dr. Caselli is professor of neurology at the Mayo Clinic College of Medicine and the clinical core director of the Arizona Alzheimer’s Disease Center. He also is the Mayo Clinic’s medical director for service. He has research interests that focus on aging, Alzheimer’s disease, and other forms of dementia, particularly the way in which genetic risk factors for dementia may affect how the mind changes with age before the onset of symptomatic memory loss and dementia.

Stuart Black
STUART B. BLACK, M.D.
, Baylor University Medical Center, Dallas

Dr. Black is chief of neurology and codirector of the Neuroscience Center at Baylor University Medical Center at Dallas. He was a founding member and is past president of the Texas Neurological Society and was chairman of the Texas Medical Association’s Section of Neurology. He was on the University of Texas Southwestern Medical School clinical faculty for 37 years and was a clinical professor of neurology. Dr. Black specializes in headache and facial pain and has interests in coding and medical economics.

Jeffrey Buchhalter
JEFFREY R. BUCHHALTER
, Alberta Children’s Hospital, Calgary

Dr. Buchhalter is professor of pediatrics and clinical neurosciences and director of the Children's Comprehensive Epilepsy Centre at Alberta Children’s Hospital in Calgary. His past research efforts have spanned from the testing of new antiepileptic drugs to outcome studies from epilepsy surgery to the genetic epidemiology of epilepsy in the community setting. His current interests are focused on developing care pathways and statistically meaningful outcome measures in order to: 1) improve the quality of life for children with epilepsy; 2) collect deep phenotypic profiles that will be essential for understanding phenotype-genotype relationships; and 3) provide a baseline onto which novel therapies derived from translational laboratory studies can be tested. He is also interested in determining the effect of metabolic therapies in individuals with autism who may or may not have epilepsy as a comorbidity.

Jonathan Carter
JONATHAN L. CARTER, M.D.
, Mayo Clinic Arizona

Dr. Carter is associate professor of neurology at the Mayo Clinic College of Medicine and a consultant in the department of neurology at the Mayo Clinic Arizona. He also is the associate program director of the neurology residency program, MS fellowship program director, and director of the neurology medical student clerkships at the Mayo Clinic Arizona. His research interests have focused on clinical research involving new therapeutic modalities for multiple sclerosis, including both investigator-initiated and industry-sponsored Phase I, II, and III studies. He also is interested in clinical and MRI variants of multiple sclerosis and in mimics of multiple sclerosis.

Joseph Drazkowski
JOSEPH F. DRAZKOWSKI, M.D.
, Mayo Clinic Arizona

Dr. Drazkowski is associate professor of neurology at the Mayo Clinic College of Medicine. He is the program director of the Mayo’s fellowship in clinical neurophysiology, EEG, and epilepsy. He also directs the EEG laboratory and codirects the epilepsy monitoring unit at the Mayo Clinic Arizona. His research interests have been focused primarily on social issues that confront patients with epilepsy (especially driving and quality of life).

Mark Hallett
MARK HALLETT, M.D.
, National Institutes of Health, Bethesda, Md.

Dr. Hallett is currently chief of the Medical Neurology Branch and chief of the Human Motor Control Section of the National Institute for Neurological Disorders and Stroke in Bethesda, Md. He has been president of the Movement Disorder Society and vice president of the American Academy of Neurology. His research activities focus on the physiology of human voluntary movement and its pathophysiology in disordered voluntary movement and involuntary movement.

Susanna Horvath
SUSANNA HORVATH, M.D.
, Columbia Presbyterian Hospital, New York

Dr. Horvath is an assistant clinical professor of neurology at Columbia University Medical Center, New York. She is also the chief of neurology at the Allen Hospital in New York. Her subspecialty is stroke, with board certification in vascular neurology. Dr. Horvath also works as a general neurologist. She is a member of the American Academy of Neurology, the American Stroke Association, and sits on the New York City Stroke Council.

Matthew Huentelman
MATTHEW J. HUENTELMAN, Ph.D.
, Translational Genomics Research Institute, Phoenix, Ariz.

Dr. Huentelman is an associate professor in the neurogenomics division at the nonprofit Translational Genomics Research Institute in Phoenix, where his research interests center around the investigation of the genomics, transcriptomics, and proteomics of neurological traits and disease. His laboratory's overarching goal is to leverage findings in these disciplines to better understand, diagnose, and treat human diseases of the nervous system. His laboratory focuses on the study of autism, Alzheimer's disease, aging, and diseases with a significant aging component.

Irene Litvan
IRENE LITVAN, M.D.
, University of California, San Diego

Dr. Irene Litvan is the Tasch Endowed Chair of Parkinson Disease Research, professor of neurosciences, and director of the movement disorder program at the University of California, San Diego. She is currently the secretary of the World Federation of Neurology Research Group on Dementia and member of the medical scientific boards of CurePSP, PSP Europe Association, and the Association for Frontotemporal Degeneration. She is the CEO and Founder of the Litvan Neurological Research Foundation, whose mission is to increase awareness, determine the cause(s) and search for a cure for neurodegenerative disorders presenting with either parkinsonian or dementia symptoms.

Katherine Noe
KATHERINE H. NOE, M.D., PH.D.
, Mayo Clinic Arizona

Dr. Noe is assistant professor of neurology at the Mayo Clinic College of Medicine and a consultant in the division of epilepsy at the Mayo Clinic Arizona. Her research interests include women’s issues in epilepsy, functional imaging, psychogenic seizures, and safety and quality in epilepsy care.

Alyx Porter
ALYX B. PORTER, M.D.
, Mayo Clinic Arizona

Dr. Porter is an assistant professor of neurology at the Mayo Clinic College of Medicine and a senior associate consultant in the department of neurology and the division of hematology/oncology at the Mayo Clinic Arizona. Her research interests include the treatment of low- and high-grade meningiomas and new and recurrent glioblastomas, the prevention of radiation-induced cognitive dysfunction, and the effect of steroids on the diagnosis of primary central nervous system lymphoma.

Marwan Sabbagh
MARWAN N. SABBAGH, M.D.
, Sun Health Research Institute, Sun City, Ariz.

Dr. Sabbagh is the director of the Banner Sun Health Research Institute, Sun City, Ariz., and is the chief medical/scientific officer at the institute. He is also the associate director of the Arizona Alzheimer’s Disease Core Center and a clinical instructor in the Banner/St. Joseph’s Hospital’s Geriatric Fellowship Program. He is a visiting scientist in the department of neurology at the Mayo Clinic in Scottsdale, Ariz. He also is an adjunct professor at Midwestern University and Arizona State University.

Benn Smith
BENN E. SMITH, M.D.
, Mayo Clinic Arizona

Dr. Smith is an associate professor of neurology at the Mayo Clinic College of Medicine. At the Mayo Clinic Arizona, he is director of the sensory laboratory and is currently working on the design and implementation of an evoked potential clinical research laboratory. His research interests have focused on peripheral neuropathies and the treatment and diagnosis of small fiber neuropathy and other neuromuscular disorders.

Richard Zimmerman
RICHARD S. ZIMMERMAN, M.D.
, Mayo Clinic Arizona

Dr. Zimmerman is associate professor of neurosurgery at the Mayo Clinic College of Medicine and associate dean of the Mayo School of Graduate Medical Education. His neurosurgical practice at the Mayo Clinic Arizona focuses on the epilepsy surgery, microneurosurgery (for trigeminal neuralgia and hemifacial spasm), brain tumor and skull-base surgery, facial pain and trigeminal neuralgia, and vascular neurosurgery (AVMs, aneurysms, and carotid endarterectomy). For 10 years, Dr. Zimmerman served as Medical Director of Mayo Clinic Hospital. He chaired the Mayo Clinic Quality Care Subcommittee, which integrates and coordinates quality and safety initiatives for the Mayo Foundation at all Mayo Clinic sites.